HEPATITIS D, CHRONIC

Clinical trials for HEPATITIS D, CHRONIC explained in plain language.

Never miss a new study

Get alerted when new HEPATITIS D, CHRONIC trials appear

Sign up with your email to follow new studies for HEPATITIS D, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 2

New drug enters final testing to control devastating liver virus

Disease control Not yet recruiting

This study is testing whether a new drug called Hepalatide (L47) can help control chronic hepatitis D, a serious liver infection. About 150 patients will receive either the drug or a placebo for 48 weeks, while doctors monitor their virus levels and liver health. The goal is to s…

Matched conditions: HEPATITIS D, CHRONIC

Phase: PHASE3 • Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

HEPATITIS D, CHRONIC

Get alerted when new HEPATITIS D, CHRONIC trials appear

New drug enters final testing to control devastating liver virus